Viewing Study NCT04756505

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-01-17 @ 8:44 AM
Study NCT ID: NCT04756505
Status: WITHDRAWN
Last Update Posted: 2023-12-27
First Post: 2021-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anatomic Stage IV Breast Cancer AJCC v8 View
None Hormone Receptor Positive Breast Adenocarcinoma View
None Metastatic Breast Carcinoma View
None Metastatic HER2 Negative Breast Adenocarcinoma View
None Prognostic Stage IV Breast Cancer AJCC v8 View
Keywords: